May 18, 2019 Clinical Research/Diagn. Lab Top-10 Product Launch

New State-of-the-Art Facility Increases Agilent's Capacity to Produce Nucleic Acid-Based Therapeutics

New State-of-the-Art Facility Increases Agilent’s Capacity to Produce Nucleic Acid-Based Therapeutics New facility in Frederick, Colorado, to produce high-quality molecules with the potential to treat cancer and other diseases SANTA CLARA, Calif., June 18, 2019 Agilent Technologies Inc. (NYSE: A) today announced the opening of a production facility in Colorado that more than doubles its... Read more

May 16, 2019 Clinical Research/Diagn.

QIAGEN and Inovio collaborate to develop companion diagnostic for novel immunotherapy targeting precancerous cervical lesions

Hilden, Germany, Germantown, Maryland, and Plymouth Meeting, Pennsylvania, May 16, 2019 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) and Inovio Pharmaceuticals Inc. (NASDAQ: INO) today announced a collaboration to co-develop a companion diagnostic to guide clinical decision-making for the use of Inovio’s DNA-based immunotherapy to treat cervical dysplasia caused by human papillomavirus (HPV).... Read more

May 15, 2019 Acad, Gov/Utilities Clinical Research/Diagn. Lab Top-10 Product Launch

New Study Demonstrates Clinical Utility of Liquid Biopsy for Cancer Monitoring

Multi-institutional clinical research indicates liquid biopsy can detect changes in tumor profile and resistance to treatment CARLSBAD, Calif., May 15, 2019 /PRNewswire/ — Growing scientific evidence supports liquid biopsy as a valuable tool for monitoring treatment response in patients with cancer. A new retrospective clinical research study showing comparable results between liquid and tissue biopsy in... Read more

May 15, 2019 Clinical Research/Diagn. Liq. Handling & Robotics

GE Healthcare announces commercial launch of Chronicle™ automation software for cell therapy

May 15, 2019 – GE Healthcare builds on its digital capabilities with the Chronicle web application, the next generation development of my.Cryochain™ software now supporting the complete cell therapy workflow. Chronicle automation software is a GMP compliant fit-for-purpose digital solution designed to optimize complex cell therapy process development and manufacturing. With real-time supply chain tracking,... Read more

May 14, 2019 Clinical Research/Diagn.

GE Healthcare and Indi Molecular to collaborate on diagnostic tool for clinical management of immunotherapy patients

Chalfont St Giles, UK & Culver City, CA, May 14 2019 – GE Healthcare and Indi Molecular, Inc, a  California-based biotechnology company, have announced plans to develop immune cell-targeted Positron-Emission Tomography (PET) tracer candidates, based on Indi Molecular’s proprietary Protein Catalyzed Capture (PCC) technology. These tracer candidates, if successful, could help identify molecular markers of cytotoxic T-cells,... Read more

May 14, 2019 Clinical Research/Diagn. Product Launch

New Roche test aids clinicians in accelerating tuberculosis diagnosis and treatment by detecting antimicrobial resistance within the world’s leading cause of infectious disease deaths

Basel, 14 May 2019 New Roche test aids clinicians in accelerating tuberculosis diagnosis and treatment by detecting antimicrobial resistance within the world’s leading cause of infectious disease deaths New tests on cobas 6800/8800 systems provide clinicians information to help speed treatment and reduce the spread of infection Rising challenge of drug resistance compounds the tuberculosis... Read more

May 14, 2019 Atomic Spectroscopy Clinical Research/Diagn. M&A, Partnerships

Roche and Spark Therapeutics, Inc. announce expected refiling date of Premerger Notification and Report Forms under the HSR Act and extension of tender offer for shares of Spark Therapeutics, Inc.

Basel, 14 May 2019 Roche and Spark Therapeutics, Inc. announce expected refiling date of Premerger Notification and Report Forms under the HSR Act and extension of tender offer for shares of Spark Therapeutics, Inc. Parties elect to refile Premerger Notification and Report Forms on or about 23 May 2019 to provide the government with additional... Read more

May 13, 2019 Clinical Research/Diagn. Lab Top-10 M&A, Partnerships Microscopy

Bruker and Champalimaud Foundation Announce Collaboration to Develop Novel Ultra-High Field 18 Tesla Preclinical MRI System and Applications

World’s highest field preclinical MRI will be used for oncology and neuroscience research MONTREAL, May 13, 2019 /PRNewswire/ — At the Annual Meeting of the International Society for Magnetic Resonance in Medicine (ISMRM), Bruker today announced an agreement to develop the world’s first 18 Tesla 11 cm bore, preclinical ultra-high field (UHF) magnetic resonance imaging... Read more

May 10, 2019 Clinical Research/Diagn. PR/Corporate Product Launch

Roche to present new data highlighting comprehensive approach to cancer care at 2019 American Society of Clinical Oncology (ASCO) Annual Meeting

Basel, 10 May 2019 Roche to present new data highlighting comprehensive approach to cancer care at 2019 American Society of Clinical Oncology (ASCO) Annual Meeting Study results across 17 medicines reflect our commitment to personalised care with advances in targeted therapies, immunotherapy, and diagnostics, data and analytics New pivotal data on fixed-duration combination of Venclexta/Venclyxto... Read more

May 9, 2019 Clinical Research/Diagn. PR/Corporate

Two Pore Guys Rebranded as Ontera Under New Leadership to Bring NextGeneration Molecular Diagnostics to the Field and Point of Use

Murielle Thinard-McLane Appointed New CEO Santa Cruz, Calif. — May 9, 2019 — Two Pore Guys, Inc., the leader in silicon-based nanopore diagnostics, has rebranded as Ontera Inc. to reflect its broader mission of providing better biological information for a healthier planet. As part of these changes, the company has appointed two seasoned executives to... Read more